High-grade serous ovarian cancer (HGSOC), triple-negative breast cancer, and a subset of endometrial cancers frequently share mutations in the TP53 gene, one of the most frequently mutated tumor suppressor genes across human cancers. This evidence concerns the gene TP53 and cancer.